Female Viagra
Female Viagra Price range: $ 41,00 through $ 305,00
Back to products
Femalegra
Femalegra Price range: $ 50,00 through $ 305,00

Femalefil

Price range: $ 46,00 through $ 89,00

Femalefil is an effective medication designed to help women address sexual health concerns by utilizing the active ingredient Tadalafil. It works by increasing blood flow to the pelvic region, which significantly enhances sensitivity and responsiveness during intimate moments. This formula is specifically developed to manage Female Sexual Arousal Disorder, allowing for a more fulfilling and comfortable experience. One of its key advantages is a long-lasting window of effectiveness, providing flexibility and reducing the need for immediate planning. By supporting natural arousal processes, Femalefil helps restore confidence and improves overall satisfaction in personal relationships.

Active substance: Tadalafil
SKU: Femalefil Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Femalefil belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors, containing the active substance tadalafil. While tadalafil is FDA-approved in the United States for specific indications such as erectile dysfunction and pulmonary arterial hypertension, its application for female sexual arousal disorder is an off-label use. Prescription formulations containing tadalafil are dispensed in accordance with applicable federal and state regulations.

This medical overview provides structured factual information regarding the mechanism, clinical profile, pharmacokinetics, and safety parameters of Femalefil for educational reference.

Basic Information and Overview

Property Details
Drug Name Femalefil
Active Ingredient (INN) Tadalafil
Therapeutic Class Phosphodiesterase Type 5 (PDE5) Inhibitor
Dosage Form Oral tablet
Route of Administration Oral
Prescription Status Dispensed in accordance with applicable federal and state regulations
Storage Conditions Store at 59°F to 86°F (15°C to 30°C) away from moisture

Clinical Profile and Usage Guidelines

Key Pharmacological Properties

How the drug works

The active component of Femalefil is tadalafil, which operates through selective inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Under normal physiological conditions, local sexual stimulation prompts the release of nitric oxide, which subsequently activates the enzyme guanylate cyclase. This enzymatic activation leads to elevated concentrations of cGMP, causing vascular smooth muscle relaxation and enhanced blood flow to pelvic tissues. By inhibiting PDE5-mediated degradation of cGMP, tadalafil helps sustain increased cGMP levels, maintaining vascular relaxation in genital tissues.

What it’s used for

In the United States, tadalafil is officially FDA-approved for the treatment of adult erectile dysfunction and pulmonary arterial hypertension. The specific product formulation marketed as Femalefil has been used off-label for female sexual arousal disorder (FSAD) and hypoactive sexual desire disorder. Off-label use refers to the administration of an FDA-approved active ingredient for an indication not explicitly detailed in its approved prescribing label. Clinical evidence regarding PDE5 inhibitor efficacy in female populations remains variable, and treatment must be evaluated on an individual basis by a licensed healthcare provider.

What happens in the body

Following oral administration, tadalafil is absorbed efficiently, achieving peak plasma concentration (Cmax) within an average time frame of 2 hours post-dose. The absolute rate and extent of absorption are not meaningfully affected by food. Tadalafil exhibits a prolonged terminal elimination half-life of approximately 17.5 hours in healthy adults, allowing for extended therapeutic potential of up to 36 hours. Hepatic metabolism occurs predominantly through the cytochrome P450 3A4 (CYP3A4) pathway. Excretion occurs primarily as inactive metabolites, with approximately 61% eliminated in feces and 36% excreted via urine.

Dosing and Administration

Dosing schedule

Femalefil is generally formulated as an oral tablet containing 10 mg of tadalafil. The administration schedule depends on the therapeutic strategy outlined by a healthcare clinician. When used on a situational basis, the tablet is swallowed whole with water approximately 30 to 60 minutes prior to anticipated sexual activity. Dosage adjustments are necessary for patients with impaired renal function; for instance, individuals with moderate renal impairment (creatinine clearance 30 to 50 mL/min) require a reduced maximum dose. Severe renal insufficiency or severe hepatic impairment (Child-Pugh Class C) warrants extreme caution or avoidance. Patients should not administer more than one dose within a 24-hour window.

What you may notice early on

Following administration, physical changes associated with vascular relaxation typically manifest between 30 and 60 minutes. Early systemic effects may include mild facial flushing, slight nasal congestion, or a mild sensation of vascular warmth. Patients evaluating off-label efficacy should note that physical stimulation remains necessary for systemic vascular actions to yield physiological changes. Initial trials assist healthcare providers in establishing tolerance and adjusting therapy as clinically necessary.

Signs of improvement

Clinical efficacy for off-label indications is evaluated primarily through subjective symptom assessment and functional improvement. Observed indicators may include improved local genital tissue engorgement, heightened sensitivity, and enhanced physiological lubrication during stimulation. Because individual response is influenced by baseline hormonal status, underlying physiological conditions, and neurovascular health, therapeutic progress should be monitored through routine clinical follow-ups.

Safety, Warnings, and Interactions

What not to combine

Co-administration of Femalefil with organic nitrates (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) or nitric oxide donors is strictly contraindicated. Combined use can trigger a precipitous and potentially life-threatening drop in blood pressure. Concomitant administration with alpha-adrenergic blockers (e.g., tamsulosin, doxazosin) may induce symptomatic orthostatic hypotension. Strong CYP3A4 inhibitors (including ketoconazole, itraconazole, and ritonavir) significantly increase systemic tadalafil exposure, whereas strong CYP3A4 inducers (such as rifampin) accelerate clearance, reducing overall effectiveness.

Adverse reactions

Adverse reactions associated with tadalafil primarily stem from its systemic vasodilatory properties. Commonly reported mild-to-moderate side effects include headache, dyspepsia (gastrointestinal upset), back pain, myalgia (muscle aches), nasal congestion, and facial flushing. Most mild adverse events resolve spontaneously. Rare but severe adverse events reported with PDE5 inhibitors include sudden vision impairment attributed to non-arteritic anterior ischemic optic neuropathy (NAION), sudden hearing reduction, severe hypersensitivity reactions, and profound hypotension.

Important precautions

Prescribing caution is required for patients with pre-existing cardiovascular conditions, including recent myocardial infarction, unstable angina, severe heart failure, or uncontrolled cardiac arrhythmias, as sexual exertion confers inherent cardiovascular risks. Femalefil should be evaluated carefully in individuals with severe renal impairment, hepatic dysfunction, or bleeding disorders. Safety during pregnancy and lactation has not been formally established for female sexual dysfunction indications; use during pregnancy should occur only if explicitly deemed necessary by a managing physician.

What to avoid while taking it

Femalefil can be ingested independently of meals, as dietary intake does not significantly modify tadalafil bio-availability. However, substantial alcohol consumption should be avoided while taking this medication. Alcohol and tadalafil both act as mild vasodilators; combining them increases the risk of orthostatic symptoms, including dizziness, orthostatic hypotension, reflex tachycardia, and headache. In addition, grapefruit juice should be limited, as it inhibits CYP3A4 metabolism and may increase plasma drug concentrations.

Storage and expiration

Femalefil tablets must be stored at controlled room temperature, ideally between 59°F and 86°F (15°C to 30°C). Keep the product in its original container, protected from excessive heat, direct sunlight, and moisture. Store all medications safely out of reach of children and domestic animals. Expired or unused tablets should be disposed of via proper drug take-back programs or according to standard environmental guidance, rather than being discarded in household waste or municipal water systems.

Frequently Asked Questions

What should be done if a scheduled dose of Femalefil is missed?

If Femalefil is prescribed on an as-needed basis, missed dose protocols are not applicable. If prescribed as a daily regimen and a dose is missed, take the tablet as soon as remembered on that day. If it is nearly time for the next scheduled dose, skip the missed dose and resume the normal daily schedule. Never double the dose to compensate for a missed tablet.

Is it safe to drive or operate heavy machinery after taking Femalefil?

Tadalafil may cause side effects such as dizziness, lightheadedness, or transient visual disturbances in some individuals. Patients should observe their individual physical reaction to the medication before driving, operating heavy machinery, or engaging in tasks requiring complete mental alertness.

How long does tadalafil remain active in the systemic circulation?

Tadalafil has a half-life of approximately 17.5 hours, which is longer than that of many other PDE5 inhibitors. Active drug concentrations may remain present in the bloodstream for up to 36 hours after ingestion. This extended presence should be considered when assessing drug-drug interaction potential with newly prescribed medications.

Can Femalefil be combined with over-the-counter pain relievers for headache management?

Mild headaches caused by vasodilation may sometimes be managed with standard non-prescription analgesics such as acetaminophen. However, patients should consult a pharmacist or physician before combining analgesics, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), if they have underlying renal, gastrointestinal, or cardiovascular risk factors.

What emergency measures are necessary if an allergic reaction occurs?

Signs of a severe allergic reaction include facial swelling, severe skin rash, hives, difficulty breathing, or swelling of the lips, tongue, and throat. If any of these symptoms develop after taking Femalefil, emergency medical care must be sought immediately.


In accordance with FDA requirements: Information on this page is for reference and does not replace an assessment by a licensed healthcare professional. Dispensed in accordance with applicable federal and state regulations.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

10 mg

Package

40 pills

,

60 pills

,

120 pills

Ενεργός Ουσία